Subretinal Delivery Of RGX-314 For Neovascular AMD: A Phase II Pharmacodynamic Study
Charles C. Wykoff MD, PhD, Director of Research at Retina Consultants of Texas; Chairman of Research, Retina Consultants of America; and Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital